+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Cell Penetrating Peptides - Global Strategic Business Report - Product Thumbnail Image

Cell Penetrating Peptides - Global Strategic Business Report

  • Report
  • June 2025
  • 371 Pages
  • Global
From
From
From
From
From
From
GLP-1 Receptor Agonist Market Report 2025 - Product Thumbnail Image

GLP-1 Receptor Agonist Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Catalepsy Treatment Market Report 2025 - Product Thumbnail Image

Catalepsy Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Recombinant Proteins Market 2025-2029 - Product Thumbnail Image

Recombinant Proteins Market 2025-2029

  • Report
  • April 2025
  • 203 Pages
  • Global
From
Loading Indicator